Back
Accelerate Diagnostics 10K Form
Sell
32
AXDX
Accelerate Diagnostics
Last Price:
0.88
Seasonality Move:
23.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AXDX News And Ratings
See the #1 stock for the next 7 days that we like better than AXDX
AXDX Financial Statistics
Sales & Book Value
Annual Sales: | $12.06M |
---|---|
Cash Flow: | $-8.97M |
Price / Cash Flow: | 0 |
Annual Sales: | $-1.18 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -4.46000 |
---|---|
Net Income (TTM): | $-59.05M |
Gross Margin: | $2.55M |
Return on Equity: | 0% |
Return on Assets: | -145.96% |
Accelerate Diagnostics Earnings Forecast
Key Accelerate Diagnostics Financial Ratios
- The Gross Profit Margin over the past 28 years for AXDX is 21.15%.
- The Selling, General & Administrative Expenses for AXDX have been equal to 258.94% of Gross Profit Margin.
- The Research & Development expenses have been 210.24% of Revenue.
- The Interest Expense is -12.57% of Operating Income.
- The Net Earning history of AXDX is -510.97% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 13 years.
Accelerate Diagnostics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | AXDX |
CUSIP: | 00430H |
Website: | acceleratediagnostics.com |
Debt
Debt-to-Equity Ratio: | -1.49 |
---|---|
Current Ratio: | 1.5 |
Quick Ratio: | 1.11 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
AXDX Technical Analysis vs Fundamental Analysis
Sell
32
Accelerate Diagnostics (AXDX)
is a Sell
Is Accelerate Diagnostics a Buy or a Sell?
-
Accelerate Diagnostics stock is rated a Sell
The current Accelerate Diagnostics [AXDX] share price is $0.88. The Score for AXDX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.